CIMS Global

CIMS Global is a data science company specializing in innovative solutions for clinical trials, serving pharmaceutical companies and contract research organizations (CROs) across all phases of drug development. Headquartered in New Jersey with offices in China and Taiwan, CIMS Global leverages proprietary technologies — including Artificial Intelligence (AI), Large Language Models (LLMs), and Machine Learning (ML) — combined with advanced statistical methodologies to accelerate and enhance the quality and efficiency of clinical trial data acquisition, processing, analysis, and regulatory submissions.

With over 16 years of industry experience and a track record spanning more than 1,600 global clinical trials, CIMS Global's mission is to produce groundbreaking tools that reduce trial costs and timelines, enabling life-saving therapies to reach patients sooner. The company's proprietary technology is supported by published research and is trusted by leading pharmaceutical companies and CROs worldwide.

Key Products and Modules

• DMC-HUB: A centralized management platform that empowers technology and provides an independent working environment for the entire Independent Data Monitoring Committee (IDMC) process. DMC-HUB stores all related aspects of the IDMC workflow in one convenient location, boosting efficiency and maintaining consistency throughout the process.
• eBinder™: A data management tool that improves the quality and efficiency of clinical trials by automatically uploading patient information into a secure database, eliminating the need for manual data entry. eBinder™ can be integrated with Electronic Data Capture (EDC) and Source Data Capture (SDC) systems or used as a standalone tool, keeping patient information safe and secure from source to cloud.
• CIMS DDM™: An AI-engineered statistical package designed for dynamically monitoring and optimizing clinical trial progress. DDM™ enables Independent Data Monitoring Committees to make accurate, confident decisions and is integrated with CIMS's EDC and Interactive Web Response System (IWRS) to form a closed system capable of running complex statistical and mathematical computations and simulations.
• eClinical Solutions: An integrated suite including EDC and IWRS that connects with CIMS DDM™ to create a closed system for comprehensive trial management and real-time monitoring.
• Innovative Solutions Suite: A broader set of tools that push the boundaries of clinical trial management, including capabilities for predicting trial outcomes and automating site data capture processes.

Core Capabilities and Trial Optimization Features

• Trial optimization: Ongoing trial optimization to maximize the probability of success throughout the trial lifecycle.
• Early termination of hopeless trials: Automated alerts to conduct formal futility analyses, enrich patient populations, or modify sample sizes before resources are wasted.
• Drug safety detection: Continuous monitoring of drug safety signals throughout the trial.
• Dose selection: Optimization of Phase 2/3 combination trials by identifying the most promising doses for Phase 3 advancement.
• Population selection: Intelligent identification of the most effective subpopulations, applicable to both randomized controlled trials (RCTs) and real-world evidence (RWE) settings for personalized medicine.
• Sample size re-estimation: Intelligent estimation of optimal sample sizes to maximize the probability of trial success.
• Model checking and correction: Verification and correction of assumptions established prior to trial initiation.

Technology Infrastructure and Notable Details

• Proprietary closed system: CIMS Global's integrated ecosystem connects every step of the clinical trial, enabling real-time monitoring, proactive safety adjustments, and dynamic course correction. This closed system can determine whether a drug is working or failing in nearly half the time of the current industry standard.
• Cutting-edge eClinical suite: An intuitive platform that simplifies data management, streamlines workflows, and fosters collaboration across research teams.
• AI and machine learning: Harnessing pioneering data technology to unlock hidden insights, optimize trial design, and support faster, data-driven decision-making.
• GxP compliance: CIMS Global's platforms are designed to meet GxP regulatory standards, supporting compliant data science environments for clinical research.
• Dynamic Trial Design: CIMS's approach to dynamic trial design has been recognized by industry partners as a significant driver of cost reduction in clinical development.
• Global presence: Offices in New Jersey (headquarters), China, and Taiwan, supporting a global client base of pharmaceutical companies and CROs.

CIMS Global bridges the gap between visionary researchers and effective treatments by combining a powerful eClinical toolkit, proprietary AI-driven analytics, and deep statistical expertise — all aimed at accelerating drug development and generating more favorable clinical outcomes.